Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Prior Treartment Failures with Glecaprevir/Pibrentasvir (G/P) in Chronic Hepatitis C Infection
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure - ScienceDirect
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs - ScienceDirect
Treatment With SOF/VEL or SOF/VEL/VOX Is Well Tolerated and Results in High SVR12 in Genotype 1-6 HCV-Infected Patients With Minimal Fibrosis: a Retrospective Analysis of the ASTRAL and POLARIS Clinical Studies
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan,Hepatology International - X-MOL
Sofosbuvir/Velpatasvir/Voxilaprevir: A Highly Effective Option for Retreatment of Hepatitis C in Difficult-to-treat Patients - Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson, 2019
SOF/VEL/VOX per l'epatite C cronica • NCF - Notiziario Chimico Farmaceutico
Tractament antiviral de l'hepatitis C crònica
Prevalencia de las potenciales interacciones medicamentosas entre los antivirales de acción directa pangenotípicos y la medicación concomitante asociada a los pacientes con infección del virus de la hepatitis C crónica en España
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
The Clinical Development of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX, Vosevi®) | SpringerLink
Vox JamVOX III - DJMania
SciELO - Brasil - Three regimens for re-treatment failure of Sofosbuvir-based therapy for chronic hepatitis-C genotype-4: a cohort study Three regimens for re-treatment failure of Sofosbuvir-based therapy for chronic hepatitis-C genotype-4: a
Hepatitis C. No respondedores, tienen otra alternativa
Vosevi Coadministration with Vitamins/Supplements
PDF) Efficacy of sofosbuvir/velpatasvir/voxilaprevir in direct-acting antiviral experienced patients with hepatitis C virus
Sofosbuvir-Velpatasvir-Voxilaprevir Vosevi - Treatment - Hepatitis C Online
Sofosbuvir Sovaldi - Treatment - Hepatitis C Online
Informe de Posicionamiento Terapéutico de sofosbuvir/velpatasvir/voxilaprevir (Vosevi®) en hepatitis C
SOF/VEL/VOX and Other Sofosbuvir-Based Direct-Acting Antiviral Therapies for Hepatitis C Virus in Patients Receiving Opioid Substitution Therapy: An Analysis. - ppt download
Sofosbuvir, Velpatasvir, and Voxilaprevir (SOF/VEL/VOX) VOSEVI® Criteria for Use December 2019
SOF/VEL/VOX Effective as Retreatment for Non-NS5A DAA Failures - MPR
